O’Melveny & Myers LLP has advised TTM Technologies, Inc. TTM Technologies, Inc. has secured a new US$1 billion cash flow senior secured revolving credit facility and...
TTM Technologies Secures US$1.4 Billion Senior Secured Credit Facilities
Time Interconnect Technology Raises HK$2.9 Billion Through Share Placement
O’Melveny has represented Macquarie Capital Limited, as overall coordinator, sole placing agent, and sole capital market intermediary. Time Interconnect Technology Limited has successfully conducted a share...
eHi Car Services Completes US$152 Million Bond Exchange Offer
O’Melveny has advised eHi Car Services Limited. eHi Car Services Limited has successfully completed a bond exchange offer and exit consent solicitation valued at US$152 million....
Tiantu Capital Sells Yoplait China Stake for RMB1.8 Billion
O’Melveny & Myers has advised Tian Tu Capital Co., Ltd. on the sale of its interest in Yoplait Dairy Co., Ltd. and on related Hong Kong...
Distinct Healthcare Holdings Completes HK$285 Million IPO and Hong Kong Listing
O’Melveny & Myers LLP has advised Distinct Healthcare Holdings Limited on its initial public offering and listing. Distinct Healthcare Holdings Limited has completed its initial public...
Pharmaron Completes HK$1.33 Billion H Share Placement
O’Melveny & Myers has advised Pharmaron Beijing Co., Ltd. Pharmaron Beijing Co., Ltd. has finalized a placing of 58,440,762 new H shares under a general issuance...
TransThera Sciences Completes HK$190 Million Placement of New H Shares
O’Melveny & Myers has advised TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. has completed the placement of 2,100,000 new H shares under a general mandate,...
CNGR Advanced Material Completes US$450 Million A+H Share Listing on Hong Kong Stock Exchange
O’Melveny has advised the joint sponsors and underwriters. CNGR Advanced Material Co., Ltd. has completed its A+H share listing on the Main Board of the Hong...
Keymed Biosciences Completes US$108 Million Top-up Placement
O’Melveny has advised Keymed Biosciences. Keymed Biosciences has completed a top-up placement valued at approximately US$108 million (about HK$854 million). The transaction involved a placement of...
Ruichang International’s HK$131 Million Hong Kong IPO
O’Melveny represented Ruichang International Holdings Limited on the transaction. Ruichang International Holdings Limited (1334.HK) announced its initial public offering and listing on the Main Board of...
Beijing Fourth Paradigm Technology’s $150 Million Initial Public Offering
O’Melveny represented the sole sponsor, the coordinators and the underwriters in the transaction. Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) announced its initial public offering and listing...
Acotec Scientific Holdings’ Partial Offering
O’Melveny advised Acotec Scientific Holdings on the deal. Acotec Scientific Holdings, executed a voluntary partial offering for a majority stake of up to 65% by US-listed Boston...